Pulse Biosciences, Inc. (PLSE)
44.43
-1.16
(-2.54%)
USD |
NASDAQ |
Oct 16, 16:00
44.39
-0.04
(-0.09%)
Pre-Market: 20:00
Pulse Biosciences Research and Development Expense (Annual) : 44.72M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 44.72M |
| December 31, 2024 | 32.34M |
| December 31, 2023 | 27.80M |
| December 31, 2022 | 20.56M |
| December 31, 2021 | 28.64M |
| December 31, 2020 | 26.44M |
| Date | Value |
|---|---|
| December 31, 2019 | 24.96M |
| December 31, 2018 | 17.25M |
| December 31, 2017 | 9.646M |
| December 31, 2016 | 5.988M |
| December 31, 2015 | 2.578M |
| December 31, 2014 | 0.0257M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Accuray, Inc. | 37.75M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 65.85M |
| ResMed, Inc. | 378.28M |
| Rockwell Medical, Inc. | 0.00 |